Symbols

TMDX

TransMedics Group·NASDAQ

--(--)

TMDX Profile

Transmedics Group, Inc.

A medical technology company that transforming organ transplant therapy for end-stage lung, heart, and liver failure

Industry

Healthcare Technology

Established Date

Listing Date

05/02/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

898

Fiscal Year Ends

12-31

Website

www.transmedics.com

Security Type

Common stock

Office address

200 Minuteman Road, Andover, Massachusetts 01810

Business

Introduction

TransMedics Group, Inc., was founded in Massachusetts in October 2018. TransMedics, Inc., an operating company and wholly owned subsidiary of TransMedics Group, was incorporated in Delaware in August 1998. The company is a medical technology company dedicated to providing organ transplant treatment to patients with end-stage organ failure in multiple disease states. The company developed the Organ Care System (" OCS ") to replace the standard of care decades ago. OCS represents a paradigm shift that transplants organ preservation from a static to a dynamic environment, enabling new functions including organ optimization and evaluation. The company's OCS technology replicates many aspects of the natural living and functional environment of human external organs. The company has also developed its National OCS Program (" NOP "), an innovative turnkey solution that provides outsourced organ procurement, OCS perfusion management and transplant logistics services to provide a more efficient OCS donor organ procurement process for transplant programs in the United States. The company's transplant logistics services include air transportation, ground transportation and other coordination activities.